Full Text of SR0079 103rd General Assembly
SR0079 103RD GENERAL ASSEMBLY |
| | SR0079 | | LRB103 05551 ECR 50570 r |
|
| 1 | | SENATE RESOLUTION
| 2 | | WHEREAS, Hypertrophic Cardiomyopathy (HCM) is a chronic | 3 | | cardiovascular disease involving thickening of the heart | 4 | | muscle and can potentially lead to debilitating symptoms and | 5 | | serious complications, including heart failure, atrial | 6 | | fibrillation, stroke, and, in rare cases, sudden cardiac | 7 | | death; and
| 8 | | WHEREAS, HCM is the most common inheritable heart disease | 9 | | and can affect anyone regardless of age, gender, or ethnicity | 10 | | with a reported prevalence ranging from 1 in 200 to 1 in 500 in | 11 | | the general population; and
| 12 | | WHEREAS, An estimated 700,000 to 1,650,000 people in the | 13 | | United States have HCM, yet 85% of them may remain | 14 | | undiagnosed; and
| 15 | | WHEREAS, HCM shares symptoms with other common | 16 | | cardiovascular and pulmonary diseases, including shortness of | 17 | | breath, chest pain, fatigue, palpitations, and fainting; this | 18 | | makes it difficult to distinguish HCM from these other | 19 | | diseases; and
| 20 | | WHEREAS, All-cause mortality risk is three to four times | 21 | | higher in patients with HCM than that of the general |
| | | SR0079 | - 2 - | LRB103 05551 ECR 50570 r |
|
| 1 | | population; and
| 2 | | WHEREAS, Knowing one's medical history and any signs and | 3 | | symptoms of HCM are important first steps in receiving an | 4 | | accurate diagnosis of HCM; and
| 5 | | WHEREAS, A healthcare provider must conduct a thorough | 6 | | screening with cardiac health questions to help identify a | 7 | | risk of both genetic and congenital cardiac disorders; and
| 8 | | WHEREAS, A healthcare provider may conduct several tests, | 9 | | including an echocardiogram, a cardiac MRI, or genetic | 10 | | testing, to confirm a family history of HCM and must examine | 11 | | the heart to diagnose HCM; and
| 12 | | WHEREAS, Following a diagnosis of HCM, it is important for | 13 | | patients to work with their healthcare provider to learn more | 14 | | about their disease and understand different management | 15 | | options, including prescription medicines and surgical | 16 | | treatment options that may help; and
| 17 | | WHEREAS, The fourth Wednesday in February is an | 18 | | appropriate day to observe Hypertrophic Cardiomyopathy | 19 | | Awareness Day; therefore, be it
| 20 | | RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL |
| | | SR0079 | - 3 - | LRB103 05551 ECR 50570 r |
|
| 1 | | ASSEMBLY OF THE STATE OF ILLINOIS, that we declare February | 2 | | 22, 2023 as Hypertrophic Cardiomyopathy Awareness Day in the | 3 | | State of Illinois in order to raise public awareness about | 4 | | hypertrophic cardiomyopathy, a serious public health issue; | 5 | | and be it further
| 6 | | RESOLVED, That we acknowledge the critical importance of | 7 | | hypertrophic cardiomyopathy awareness to improve | 8 | | cardiovascular health in the state and support raising | 9 | | awareness of the consequences of undiagnosed and untreated | 10 | | hypertrophic cardiomyopathy and of the need to seek | 11 | | appropriate care for hypertrophic cardiomyopathy; and be it | 12 | | further
| 13 | | RESOLVED, That we respectfully urge the Governor to issue | 14 | | an annual proclamation recognizing the fourth Wednesday in | 15 | | February as Hypertrophic Cardiomyopathy Awareness Day and call | 16 | | upon the people of Illinois to observe the day with | 17 | | appropriate programs and activities.
|
|